These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 17171646

  • 1. Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-alpha.
    Liu DS, Krebs CE, Liu SJ.
    J Cell Biochem; 2007 May 15; 101(2):517-28. PubMed ID: 17171646
    [Abstract] [Full Text] [Related]

  • 2. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
    Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE.
    Clin Cancer Res; 1995 Dec 15; 1(12):1581-7. PubMed ID: 9815959
    [Abstract] [Full Text] [Related]

  • 3. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
    Dong ZY, Ward NE, Fan D, Gupta KP, O'Brian CA.
    Mol Pharmacol; 1991 Apr 15; 39(4):563-9. PubMed ID: 2017156
    [Abstract] [Full Text] [Related]

  • 4. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK, Agarwal C, Chan DC, Agarwal R.
    Oncol Rep; 2004 Feb 15; 11(2):493-9. PubMed ID: 14719089
    [Abstract] [Full Text] [Related]

  • 5. Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds.
    Wang YA, Johnson SK, Brown BL, Dobson PR.
    Oncol Rep; 2009 Feb 15; 21(2):437-42. PubMed ID: 19148520
    [Abstract] [Full Text] [Related]

  • 6. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.
    Carcinogenesis; 2009 Jul 15; 30(7):1225-33. PubMed ID: 19420016
    [Abstract] [Full Text] [Related]

  • 7. Effects of phorbol dibutyrate on cell proliferation, apoptosis, and tumor necrosis factor-alpha expression in human endometrial adenocarcinoma cells.
    Wieser F, Vigne JL, Wenzl R, Huber J, Taylor RN.
    J Soc Gynecol Investig; 2005 Jul 15; 12(5):370-5. PubMed ID: 15979550
    [Abstract] [Full Text] [Related]

  • 8. Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features.
    Devarajan E, Chen J, Multani AS, Pathak S, Sahin AA, Mehta K.
    Int J Oncol; 2002 May 15; 20(5):913-20. PubMed ID: 11956583
    [Abstract] [Full Text] [Related]

  • 9. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro.
    Sun AX, Ye ZG, Li CY, Xue BY, Li LF, Cao XF, Yang Q, Dai BQ.
    Zhongguo Yao Li Xue Bao; 1999 Jan 15; 20(1):69-73. PubMed ID: 10437129
    [Abstract] [Full Text] [Related]

  • 10. A GPIb alpha-related protein is expressed by fresh human breast carcinoma tissue and is regulated by a PKC-sensitive mechanism.
    Oleksowicz L, Dutcher JP, DeLeon-Fernandez M, Etkind P.
    Exp Cell Res; 1997 Nov 25; 237(1):110-7. PubMed ID: 9417873
    [Abstract] [Full Text] [Related]

  • 11. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H, Wallwiener D, Mueck AO.
    Gynecol Endocrinol; 2008 Oct 25; 24(10):576-9. PubMed ID: 19012101
    [Abstract] [Full Text] [Related]

  • 12. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
    Kim HH, Ahn KS, Han H, Choung SY, Choi SY, Kim IH.
    Leuk Res; 2005 Dec 25; 29(12):1407-13. PubMed ID: 15992925
    [Abstract] [Full Text] [Related]

  • 13. Effect of suramin on adenylate cyclase and protein kinase C.
    Lopez-Lopez R, Langeveld CH, Pizao PE, van Rijswijk RE, Wagstaff J, Pinedo HM, Peters GJ.
    Anticancer Drug Des; 1994 Aug 25; 9(4):279-90. PubMed ID: 7916897
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA, Khan SI.
    Cancer Chemother Pharmacol; 2009 Mar 25; 63(4):673-80. PubMed ID: 18597088
    [Abstract] [Full Text] [Related]

  • 15. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
    Wu TT, Hsieh YH, Hsieh YS, Liu JY.
    J Cell Biochem; 2008 Jan 01; 103(1):9-20. PubMed ID: 17486587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
    Shin DH, Choi KS, Park SA, Cho BS, Lee HS, Ryu JS, Kim TY, Lee CK, Song S, Chung YB.
    Arch Pharm Res; 2008 Oct 01; 31(10):1355-61. PubMed ID: 18958428
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
    Basu A.
    Mol Pharmacol; 1998 Jan 01; 53(1):105-11. PubMed ID: 9443937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.